Arsenic-induced neural tube defects in mice: Alterations in cell cycle gene expression

• Published in: Reproductive toxicology (Elmsford, N.Y.) Vol. 10; no. 6; pp. 447 - 454
• Main Authors: Wlodarczyk, Bogdan J., Bennett, Gregory D., Calvin, Jim A., Finnell, Richard H.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.11.1996; Elsevier
• Subjects: Abnormalities, Drug-Induced - etiology; Animals; arsenate; Arsenates - toxicity; Biological and medical sciences; Embryology: invertebrates and vertebrates. Teratology; Female; Fundamental and applied biological sciences. Psychology; Gene Expression - drug effects; genes; Genes, cdc - drug effects; Mice; mouse; Neural Crest - drug effects; Neural Crest - embryology; neural tube defects; Neural Tube Defects - chemically induced; Pregnancy; teratogens; Teratogens - toxicity; Teratology. Teratogens; mouse; neural tube defects; genes; teratogens; arsenate; Cell proliferation; Nervous system diseases; Embryo; Arsenic; Toxicity; Rodentia; Metal; Gene expression; Neurulation; Pregnancy; Pollutant; Vertebrata; Mammalia; Neural tube; Mouse; Malformation; Animal; Environment; Teratogen
• ISSN: 0890-6238; 1873-1708
• DOI: 10.1016/S0890-6238(96)00131-1

The potential of arsenic to cause neural tube defects (NTD) in the human population remains a topic of controversy. While clearly toxic, the lack of well-defined human epidemiologic studies on this subject has made it difficult to fully understand the effects arsenic may have on the developing human neural tube. In the absence of good clinical data, we have tried to develop a murine model where hypotheses about the reproductive toxicity of arsenate can be tested. For these studies a murine strain (LM/Bc) that has proven to be susceptible to arsenic-induced NTD was use. Because cellular proliferation is vital for normal neural tube closure (NTC) to occur, in the present study we investigated whether an acute arsenate treatment could alter the expression of several cell cycle genes during murine neurulation. Pregnant LM/Bc dams were injected intraperitoneally on gestation day (GD) 7:12 (day:hour) and 8:12 with 40 mg/kg of arsenate, a treatment that causes exencephaly in 90 to 100% of the exposed fetuses. Neural tubes were then isolated from both control and arsenic treated embryos at GD 9:00, 9:12, 10:00, and 10:12, which encompasses all the stages of neurulation for this murine strain. Using the molecular techniques of in situ transcription and antisense RNA amplification (RT/aRNA) the expression pattern for bcl-2, p53, wee-1, and wnt-1 was analyzed at each of these time points. In the neural tubes isolated from control embryos, the expression of all four genes was significantly altered as neurulation progressed, demonstrating their developmental regulation. Following arsenate treatment, however, there was a significant upregulation in the expression of bcl-2 and p53 at gestational day 9:0, compared to their control values. The heightened expression of both of these genes suggests that arsenic inhibits cell proliferation, rather than inducing apoptosis, which delayed NTC and ultimately led to the neural tube defects observed in exposed embryos.